Intradermal delivery of an immunomodulator for basal cell carcinoma; expanding the mechanistic insight in solid microneedle enhanced delivery of hydrophobic molecules.

Basal cell carcinoma (BCC) is the most common cutaneous malignancy in humans. One of the most efficacious drugs used in the management of basal cell carcinoma BCC is the immunomodulator, imiquimod....